Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Mar 22, 2018

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +3 more
  • Newport Beach, California
  • +10 more
Mar 19, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Glaucoma, Ocular Hypertension Trial in United States (0.25% AR-12286 / 0.004% travoprost, 0.5% AR-12286, 0.004% travoprost,

Completed
  • Glaucoma
  • Ocular Hypertension
  • 0.25% AR-12286 / 0.004% travoprost
  • +2 more
  • Inglewood, California
  • +8 more
Sep 12, 2016

Ocular Hypertension, Open Angle-glaucoma Trial in United States (ONO-9054, Latanoprost)

Completed
  • Ocular Hypertension
  • Open Angle-glaucoma
  • Los Angeles, California
  • +11 more
Jan 26, 2016

Glaucoma, Open-Angle, Ocular Hypertension Trial in Newport Beach (AGN-207281 ophthalmic solutions (0.1% and 0.3%); AGN-207281

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • AGN-207281 ophthalmic solutions (0.1% and 0.3%); AGN-207281 vehicle ophthalmic solution (placebo)
  • +2 more
  • Newport Beach, California
    (unnamed)
Jul 22, 2015

Glaucoma, Ocular Hypertension Trial in Newport Beach (Fixed-Combination Bimatoprost/Brimonidine, Bimatoprost Ophthalmic Solution

Completed
Has Results
  • Glaucoma
  • Ocular Hypertension
  • Fixed-Combination Bimatoprost/Brimonidine
  • +3 more
  • Newport Beach, California
    (unnamed)
Jan 16, 2015

Ocular Hypertension, Primary Open-Angle Glaucoma Trial in Newport Beach (AGN-210961 Formulation 1, AGN-210961 Formulation 2,

Completed
Has Results
  • Ocular Hypertension
  • Primary Open-Angle Glaucoma
  • AGN-210961 Formulation 1
  • +7 more
  • Newport Beach, California
    (unnamed)
Jul 10, 2014

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014

Ocular Hypertension, Glaucoma Trial in Newport Beach (bimatoprost 0.03% eye drops, latanoprost 0.005% eye drops)

Completed
Has Results
  • Ocular Hypertension
  • Glaucoma
  • bimatoprost 0.03% eye drops
  • latanoprost 0.005% eye drops
  • Newport Beach, California
    (unnamed)
Sep 19, 2011

Ocular Hypertension Trial in Newport Beach (bimatoprost)

Completed
  • Ocular Hypertension
  • Newport Beach, California
    (unnamed)
May 27, 2011

Ocular Hypertension Trial in Newport Beach (brimonidine/timolol fixed combination)

Completed
  • Ocular Hypertension
  • brimonidine/timolol fixed combination
  • Newport Beach, California
    (unnamed)
May 27, 2011

Glaucoma, Ocular Hypertension Trial in Newport Beach (Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution,

Completed
  • Glaucoma
  • Ocular Hypertension
  • Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution
  • Concurrent brimonidine 0.2% and 0.5% timolol
  • Newport Beach, California
    (unnamed)
Apr 1, 2008